UniProt ID | FUBP2_HUMAN | |
---|---|---|
UniProt AC | Q92945 | |
Protein Name | Far upstream element-binding protein 2 | |
Gene Name | KHSRP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 711 | |
Subcellular Localization | Nucleus . Cytoplasm . A small proportion is also found in the cytoplasm of neuronal cell bodies and dendrites.. | |
Protein Description | Binds to the dendritic targeting element and may play a role in mRNA trafficking (By similarity). Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting degradation machinery to ARE-containing mRNAs.. | |
Protein Sequence | MSDYSTGGPPPGPPPPAGGGGGAGGAGGGPPPGPPGAGDRGGGGPGGGGPGGGSAGGPSQPPGGGGPGIRKDAFADAVQRARQIAAKIGGDAATTVNNSTPDFGFGGQKRQLEDGDQPESKKLASQGDSISSQLGPIHPPPRTSMTEEYRVPDGMVGLIIGRGGEQINKIQQDSGCKVQISPDSGGLPERSVSLTGAPESVQKAKMMLDDIVSRGRGGPPGQFHDNANGGQNGTVQEIMIPAGKAGLVIGKGGETIKQLQERAGVKMILIQDGSQNTNVDKPLRIIGDPYKVQQACEMVMDILRERDQGGFGDRNEYGSRIGGGIDVPVPRHSVGVVIGRSGEMIKKIQNDAGVRIQFKQDDGTGPEKIAHIMGPPDRCEHAARIINDLLQSLRSGPPGPPGGPGMPPGGRGRGRGQGNWGPPGGEMTFSIPTHKCGLVIGRGGENVKAINQQTGAFVEISRQLPPNGDPNFKLFIIRGSPQQIDHAKQLIEEKIEGPLCPVGPGPGGPGPAGPMGPFNPGPFNQGPPGAPPHAGGPPPHQYPPQGWGNTYPQWQPPAPHDPSKAAAAAADPNAAWAAYYSHYYQQPPGPVPGPAPAPAAPPAQGEPPQPPPTGQSDYTKAWEEYYKKIGQQPQQPGAPPQQDYTKAWEEYYKKQAQVATGGGPGAPPGSQPDYSAAWAEYYRQQAAYYGQTPGPGGPQPPPTQQGQQQAQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSDYSTGGP ------CCCCCCCCC | 45.30 | 19413330 | |
2 | Phosphorylation | ------MSDYSTGGP ------CCCCCCCCC | 45.30 | 28188228 | |
4 | Phosphorylation | ----MSDYSTGGPPP ----CCCCCCCCCCC | 10.79 | 21406692 | |
5 | Phosphorylation | ---MSDYSTGGPPPG ---CCCCCCCCCCCC | 26.10 | 18491316 | |
6 | Phosphorylation | --MSDYSTGGPPPGP --CCCCCCCCCCCCC | 39.67 | 18491316 | |
25 | Ubiquitination | GGGGGAGGAGGGPPP CCCCCCCCCCCCCCC | 22.10 | 24816145 | |
27 | Ubiquitination | GGGAGGAGGGPPPGP CCCCCCCCCCCCCCC | 44.88 | 22053931 | |
33 | Ubiquitination | AGGGPPPGPPGAGDR CCCCCCCCCCCCCCC | 46.97 | 23000965 | |
40 | Methylation | GPPGAGDRGGGGPGG CCCCCCCCCCCCCCC | 44.75 | - | |
43 | Ubiquitination | GAGDRGGGGPGGGGP CCCCCCCCCCCCCCC | 41.78 | 23000965 | |
54 | Phosphorylation | GGGPGGGSAGGPSQP CCCCCCCCCCCCCCC | 27.32 | 28985074 | |
59 | Phosphorylation | GGSAGGPSQPPGGGG CCCCCCCCCCCCCCC | 59.60 | 27251275 | |
59 | Ubiquitination | GGSAGGPSQPPGGGG CCCCCCCCCCCCCCC | 59.60 | 23000965 | |
61 | Ubiquitination | SAGGPSQPPGGGGPG CCCCCCCCCCCCCCC | 33.56 | 21890473 | |
65 | Ubiquitination | PSQPPGGGGPGIRKD CCCCCCCCCCCHHHH | 45.07 | 23000965 | |
71 | Malonylation | GGGPGIRKDAFADAV CCCCCHHHHHHHHHH | 52.03 | 26320211 | |
71 | Methylation | GGGPGIRKDAFADAV CCCCCHHHHHHHHHH | 52.03 | 54390711 | |
71 | Ubiquitination | GGGPGIRKDAFADAV CCCCCHHHHHHHHHH | 52.03 | 22053931 | |
77 | Ubiquitination | RKDAFADAVQRARQI HHHHHHHHHHHHHHH | 8.91 | 23000965 | |
78 | Ubiquitination | KDAFADAVQRARQIA HHHHHHHHHHHHHHH | 3.99 | 23000965 | |
87 | Acetylation | RARQIAAKIGGDAAT HHHHHHHHHCCCHHH | 32.63 | 23954790 | |
87 | Ubiquitination | RARQIAAKIGGDAAT HHHHHHHHHCCCHHH | 32.63 | 23000965 | |
94 | O-linked_Glycosylation | KIGGDAATTVNNSTP HHCCCHHHCCCCCCC | 32.75 | 30059200 | |
94 | Phosphorylation | KIGGDAATTVNNSTP HHCCCHHHCCCCCCC | 32.75 | 23401153 | |
95 | O-linked_Glycosylation | IGGDAATTVNNSTPD HCCCHHHCCCCCCCC | 19.26 | 30059200 | |
95 | Phosphorylation | IGGDAATTVNNSTPD HCCCHHHCCCCCCCC | 19.26 | 29255136 | |
99 | O-linked_Glycosylation | AATTVNNSTPDFGFG HHHCCCCCCCCCCCC | 35.79 | 30059200 | |
99 | Phosphorylation | AATTVNNSTPDFGFG HHHCCCCCCCCCCCC | 35.79 | 29255136 | |
100 | Phosphorylation | ATTVNNSTPDFGFGG HHCCCCCCCCCCCCC | 29.06 | 29255136 | |
107 | Ubiquitination | TPDFGFGGQKRQLED CCCCCCCCCCCCCCC | 27.81 | 23000965 | |
109 | Acetylation | DFGFGGQKRQLEDGD CCCCCCCCCCCCCCC | 45.44 | 23749302 | |
109 | Methylation | DFGFGGQKRQLEDGD CCCCCCCCCCCCCCC | 45.44 | 91365 | |
109 | Ubiquitination | DFGFGGQKRQLEDGD CCCCCCCCCCCCCCC | 45.44 | 23000965 | |
109 (in isoform 1) | Ubiquitination | - | 45.44 | 21890473 | |
113 | Ubiquitination | GGQKRQLEDGDQPES CCCCCCCCCCCCHHH | 52.16 | 23000965 | |
120 | Phosphorylation | EDGDQPESKKLASQG CCCCCHHHHHHHHCC | 41.60 | 25159151 | |
121 | Acetylation | DGDQPESKKLASQGD CCCCHHHHHHHHCCC | 50.58 | 25953088 | |
121 | Sumoylation | DGDQPESKKLASQGD CCCCHHHHHHHHCCC | 50.58 | 25114211 | |
121 | Ubiquitination | DGDQPESKKLASQGD CCCCHHHHHHHHCCC | 50.58 | 23000965 | |
122 | Acetylation | GDQPESKKLASQGDS CCCHHHHHHHHCCCC | 59.57 | 30584043 | |
122 | Ubiquitination | GDQPESKKLASQGDS CCCHHHHHHHHCCCC | 59.57 | 23000965 | |
125 | Phosphorylation | PESKKLASQGDSISS HHHHHHHHCCCCHHH | 45.17 | 25159151 | |
125 | Ubiquitination | PESKKLASQGDSISS HHHHHHHHCCCCHHH | 45.17 | 24816145 | |
129 | Phosphorylation | KLASQGDSISSQLGP HHHHCCCCHHHHCCC | 31.06 | 25159151 | |
131 | Phosphorylation | ASQGDSISSQLGPIH HHCCCCHHHHCCCCC | 18.91 | 25159151 | |
132 | Phosphorylation | SQGDSISSQLGPIHP HCCCCHHHHCCCCCC | 27.96 | 17525332 | |
133 | Ubiquitination | QGDSISSQLGPIHPP CCCCHHHHCCCCCCC | 43.58 | 23000965 | |
137 | Ubiquitination | ISSQLGPIHPPPRTS HHHHCCCCCCCCCCC | 7.85 | 23000965 | |
143 | Phosphorylation | PIHPPPRTSMTEEYR CCCCCCCCCCCCEEE | 28.73 | 30108239 | |
144 | O-linked_Glycosylation | IHPPPRTSMTEEYRV CCCCCCCCCCCEEEC | 25.61 | 30059200 | |
144 | Phosphorylation | IHPPPRTSMTEEYRV CCCCCCCCCCCEEEC | 25.61 | 21815630 | |
146 | Phosphorylation | PPPRTSMTEEYRVPD CCCCCCCCCEEECCC | 25.98 | 28857561 | |
149 | Phosphorylation | RTSMTEEYRVPDGMV CCCCCCEEECCCCCE | 15.64 | 28985074 | |
159 | Ubiquitination | PDGMVGLIIGRGGEQ CCCCEEEEECCCHHH | 2.30 | 23000965 | |
161 | Ubiquitination | GMVGLIIGRGGEQIN CCEEEEECCCHHHHH | 18.39 | 21890473 | |
162 | Methylation | MVGLIIGRGGEQINK CEEEEECCCHHHHHH | 39.26 | 115480997 | |
169 | Acetylation | RGGEQINKIQQDSGC CCHHHHHHHHHHCCC | 43.45 | 25953088 | |
169 | Ubiquitination | RGGEQINKIQQDSGC CCHHHHHHHHHHCCC | 43.45 | 33845483 | |
174 | Phosphorylation | INKIQQDSGCKVQIS HHHHHHHCCCEEEEC | 41.58 | 20068231 | |
176 | S-nitrosocysteine | KIQQDSGCKVQISPD HHHHHCCCEEEECCC | 4.52 | - | |
176 | Glutathionylation | KIQQDSGCKVQISPD HHHHHCCCEEEECCC | 4.52 | 22555962 | |
176 | S-nitrosylation | KIQQDSGCKVQISPD HHHHHCCCEEEECCC | 4.52 | 20140087 | |
177 | 2-Hydroxyisobutyrylation | IQQDSGCKVQISPDS HHHHCCCEEEECCCC | 40.47 | - | |
177 | Acetylation | IQQDSGCKVQISPDS HHHHCCCEEEECCCC | 40.47 | 25953088 | |
177 | Ubiquitination | IQQDSGCKVQISPDS HHHHCCCEEEECCCC | 40.47 | 23000965 | |
181 | Phosphorylation | SGCKVQISPDSGGLP CCCEEEECCCCCCCC | 12.93 | 19664994 | |
184 | Phosphorylation | KVQISPDSGGLPERS EEEECCCCCCCCCCC | 37.84 | 29255136 | |
191 | O-linked_Glycosylation | SGGLPERSVSLTGAP CCCCCCCCEECCCCC | 17.88 | 30059200 | |
191 | Phosphorylation | SGGLPERSVSLTGAP CCCCCCCCEECCCCC | 17.88 | 30266825 | |
193 | Phosphorylation | GLPERSVSLTGAPES CCCCCCEECCCCCHH | 22.81 | 30266825 | |
195 | Phosphorylation | PERSVSLTGAPESVQ CCCCEECCCCCHHHH | 24.64 | 30266825 | |
200 | Phosphorylation | SLTGAPESVQKAKMM ECCCCCHHHHHHHHH | 28.87 | 30266825 | |
203 | Acetylation | GAPESVQKAKMMLDD CCCHHHHHHHHHHHH | 48.06 | 25953088 | |
203 | Ubiquitination | GAPESVQKAKMMLDD CCCHHHHHHHHHHHH | 48.06 | 23000965 | |
205 | Ubiquitination | PESVQKAKMMLDDIV CHHHHHHHHHHHHHH | 31.70 | 23000965 | |
205 (in isoform 1) | Ubiquitination | - | 31.70 | 21890473 | |
206 | Sulfoxidation | ESVQKAKMMLDDIVS HHHHHHHHHHHHHHH | 3.73 | 21406390 | |
207 | Sulfoxidation | SVQKAKMMLDDIVSR HHHHHHHHHHHHHHC | 3.51 | 28183972 | |
207 | Ubiquitination | SVQKAKMMLDDIVSR HHHHHHHHHHHHHHC | 3.51 | 23000965 | |
213 | Ubiquitination | MMLDDIVSRGRGGPP HHHHHHHHCCCCCCC | 29.38 | 23000965 | |
215 | Ubiquitination | LDDIVSRGRGGPPGQ HHHHHHCCCCCCCCC | 25.69 | 24816145 | |
234 | Phosphorylation | ANGGQNGTVQEIMIP CCCCCCCEEEEEEEC | 26.94 | - | |
237 | Ubiquitination | GQNGTVQEIMIPAGK CCCCEEEEEEECCCC | 30.13 | 23000965 | |
251 | Acetylation | KAGLVIGKGGETIKQ CCEEEECCCCHHHHH | 53.25 | 25953088 | |
251 | Ubiquitination | KAGLVIGKGGETIKQ CCEEEECCCCHHHHH | 53.25 | 23000965 | |
251 (in isoform 1) | Ubiquitination | - | 53.25 | 21890473 | |
255 | Phosphorylation | VIGKGGETIKQLQER EECCCCHHHHHHHHH | 36.43 | 22817900 | |
257 | 2-Hydroxyisobutyrylation | GKGGETIKQLQERAG CCCCHHHHHHHHHHC | 52.99 | - | |
257 | Acetylation | GKGGETIKQLQERAG CCCCHHHHHHHHHHC | 52.99 | 25953088 | |
257 | Ubiquitination | GKGGETIKQLQERAG CCCCHHHHHHHHHHC | 52.99 | 23000965 | |
257 (in isoform 1) | Ubiquitination | - | 52.99 | 21890473 | |
266 | Acetylation | LQERAGVKMILIQDG HHHHHCCEEEEEECC | 21.21 | 25953088 | |
267 | Sulfoxidation | QERAGVKMILIQDGS HHHHCCEEEEEECCC | 2.54 | 28183972 | |
274 | Phosphorylation | MILIQDGSQNTNVDK EEEEECCCCCCCCCC | 28.66 | 23401153 | |
277 | Phosphorylation | IQDGSQNTNVDKPLR EECCCCCCCCCCCEE | 29.05 | 30183078 | |
281 | 2-Hydroxyisobutyrylation | SQNTNVDKPLRIIGD CCCCCCCCCEEECCC | 41.49 | - | |
281 | Acetylation | SQNTNVDKPLRIIGD CCCCCCCCCEEECCC | 41.49 | 25953088 | |
281 | Ubiquitination | SQNTNVDKPLRIIGD CCCCCCCCCEEECCC | 41.49 | 23000965 | |
296 | Glutathionylation | PYKVQQACEMVMDIL HHHHHHHHHHHHHHH | 2.77 | 22555962 | |
298 | Sulfoxidation | KVQQACEMVMDILRE HHHHHHHHHHHHHHH | 2.81 | 21406390 | |
303 | Ubiquitination | CEMVMDILRERDQGG HHHHHHHHHHHHCCC | 3.97 | 24816145 | |
304 | Ubiquitination | EMVMDILRERDQGGF HHHHHHHHHHHCCCC | 36.92 | 23000965 | |
314 | Methylation | DQGGFGDRNEYGSRI HCCCCCCCCCCCCCC | 37.95 | 115480949 | |
315 | Ubiquitination | QGGFGDRNEYGSRIG CCCCCCCCCCCCCCC | 52.13 | 24816145 | |
317 | Phosphorylation | GFGDRNEYGSRIGGG CCCCCCCCCCCCCCC | 24.77 | 28152594 | |
319 | Phosphorylation | GDRNEYGSRIGGGID CCCCCCCCCCCCCCC | 21.59 | 28152594 | |
333 | Phosphorylation | DVPVPRHSVGVVIGR CCCCCHHHEEEEECC | 23.11 | 24719451 | |
340 | Methylation | SVGVVIGRSGEMIKK HEEEEECCCHHHHHH | 30.29 | 115480957 | |
341 | Phosphorylation | VGVVIGRSGEMIKKI EEEEECCCHHHHHHH | 33.61 | 24719451 | |
344 | Ubiquitination | VIGRSGEMIKKIQND EECCCHHHHHHHHHC | 6.58 | 21890473 | |
346 | 2-Hydroxyisobutyrylation | GRSGEMIKKIQNDAG CCCHHHHHHHHHCCC | 42.38 | - | |
346 | Acetylation | GRSGEMIKKIQNDAG CCCHHHHHHHHHCCC | 42.38 | 25953088 | |
347 | 2-Hydroxyisobutyrylation | RSGEMIKKIQNDAGV CCHHHHHHHHHCCCC | 38.30 | - | |
347 | Ubiquitination | RSGEMIKKIQNDAGV CCHHHHHHHHHCCCC | 38.30 | 24816145 | |
355 | Methylation | IQNDAGVRIQFKQDD HHHCCCCEEEEECCC | 18.97 | - | |
359 | Sumoylation | AGVRIQFKQDDGTGP CCCEEEEECCCCCCH | 36.12 | - | |
359 | 2-Hydroxyisobutyrylation | AGVRIQFKQDDGTGP CCCEEEEECCCCCCH | 36.12 | - | |
359 | Acetylation | AGVRIQFKQDDGTGP CCCEEEEECCCCCCH | 36.12 | 25953088 | |
359 | Sumoylation | AGVRIQFKQDDGTGP CCCEEEEECCCCCCH | 36.12 | - | |
359 | Ubiquitination | AGVRIQFKQDDGTGP CCCEEEEECCCCCCH | 36.12 | 33845483 | |
368 | Acetylation | DDGTGPEKIAHIMGP CCCCCHHHHHHHHCC | 48.61 | 25953088 | |
373 | Sulfoxidation | PEKIAHIMGPPDRCE HHHHHHHHCCHHHHH | 4.78 | 21406390 | |
378 | Methylation | HIMGPPDRCEHAARI HHHCCHHHHHHHHHH | 33.23 | 115480965 | |
379 | Glutathionylation | IMGPPDRCEHAARII HHCCHHHHHHHHHHH | 6.15 | 22555962 | |
394 | Methylation | NDLLQSLRSGPPGPP HHHHHHHHCCCCCCC | 44.83 | 115480973 | |
395 | Phosphorylation | DLLQSLRSGPPGPPG HHHHHHHCCCCCCCC | 62.03 | 28961369 | |
404 | Ubiquitination | PPGPPGGPGMPPGGR CCCCCCCCCCCCCCC | 41.65 | 23000965 | |
406 | Sulfoxidation | GPPGGPGMPPGGRGR CCCCCCCCCCCCCCC | 3.99 | 21406390 | |
411 | Dimethylation | PGMPPGGRGRGRGQG CCCCCCCCCCCCCCC | 37.23 | - | |
411 | Methylation | PGMPPGGRGRGRGQG CCCCCCCCCCCCCCC | 37.23 | 24129315 | |
413 | Dimethylation | MPPGGRGRGRGQGNW CCCCCCCCCCCCCCC | 30.21 | - | |
413 | Methylation | MPPGGRGRGRGQGNW CCCCCCCCCCCCCCC | 30.21 | 24129315 | |
415 | Dimethylation | PGGRGRGRGQGNWGP CCCCCCCCCCCCCCC | 32.66 | - | |
415 | Methylation | PGGRGRGRGQGNWGP CCCCCCCCCCCCCCC | 32.66 | 24129315 | |
428 | Phosphorylation | GPPGGEMTFSIPTHK CCCCCEEEEECCCCC | 15.21 | 30257219 | |
430 | Phosphorylation | PGGEMTFSIPTHKCG CCCEEEEECCCCCCC | 20.63 | 30257219 | |
433 | Phosphorylation | EMTFSIPTHKCGLVI EEEEECCCCCCCEEE | 32.09 | 30257219 | |
436 | S-nitrosocysteine | FSIPTHKCGLVIGRG EECCCCCCCEEECCC | 3.85 | - | |
436 | Glutathionylation | FSIPTHKCGLVIGRG EECCCCCCCEEECCC | 3.85 | 22555962 | |
436 | S-nitrosylation | FSIPTHKCGLVIGRG EECCCCCCCEEECCC | 3.85 | 20140087 | |
442 | Dimethylation | KCGLVIGRGGENVKA CCCEEECCCCCCHHH | 38.53 | - | |
442 | Methylation | KCGLVIGRGGENVKA CCCEEECCCCCCHHH | 38.53 | 24129315 | |
444 | Ubiquitination | GLVIGRGGENVKAIN CEEECCCCCCHHHHH | 23.19 | 21890473 | |
448 | Acetylation | GRGGENVKAINQQTG CCCCCCHHHHHHCCC | 55.95 | 26051181 | |
448 | Methylation | GRGGENVKAINQQTG CCCCCCHHHHHHCCC | 55.95 | 54390695 | |
448 | Ubiquitination | GRGGENVKAINQQTG CCCCCCHHHHHHCCC | 55.95 | 23000965 | |
461 | Phosphorylation | TGAFVEISRQLPPNG CCCEEEEECCCCCCC | 10.64 | - | |
478 | Methylation | NFKLFIIRGSPQQID CCEEEEEECCHHHHH | 34.42 | 115480989 | |
480 | Phosphorylation | KLFIIRGSPQQIDHA EEEEEECCHHHHHHH | 15.08 | 26846344 | |
483 | Ubiquitination | IIRGSPQQIDHAKQL EEECCHHHHHHHHHH | 46.60 | 22817900 | |
484 | Ubiquitination | IRGSPQQIDHAKQLI EECCHHHHHHHHHHH | 3.36 | 22817900 | |
488 | 2-Hydroxyisobutyrylation | PQQIDHAKQLIEEKI HHHHHHHHHHHHHHC | 42.07 | - | |
488 | Acetylation | PQQIDHAKQLIEEKI HHHHHHHHHHHHHHC | 42.07 | 26051181 | |
488 | Ubiquitination | PQQIDHAKQLIEEKI HHHHHHHHHHHHHHC | 42.07 | 22817900 | |
488 (in isoform 1) | Ubiquitination | - | 42.07 | 21890473 | |
502 | Ubiquitination | IEGPLCPVGPGPGGP CCCCCCCCCCCCCCC | 16.43 | 22817900 | |
509 | Ubiquitination | VGPGPGGPGPAGPMG CCCCCCCCCCCCCCC | 52.05 | 22817900 | |
510 | Ubiquitination | GPGPGGPGPAGPMGP CCCCCCCCCCCCCCC | 28.15 | 22817900 | |
577 | Ubiquitination | ADPNAAWAAYYSHYY CCCCHHHHHHHHHHC | 4.85 | 22817900 | |
583 | Phosphorylation | WAAYYSHYYQQPPGP HHHHHHHHCCCCCCC | 9.31 | 22817900 | |
583 | Ubiquitination | WAAYYSHYYQQPPGP HHHHHHHHCCCCCCC | 9.31 | 22817900 | |
584 | Ubiquitination | AAYYSHYYQQPPGPV HHHHHHHCCCCCCCC | 8.68 | 22817900 | |
585 | Ubiquitination | AYYSHYYQQPPGPVP HHHHHHCCCCCCCCC | 41.98 | 22817900 | |
602 | Ubiquitination | APAPAAPPAQGEPPQ CCCCCCCCCCCCCCC | 32.27 | 22817900 | |
609 | Ubiquitination | PAQGEPPQPPPTGQS CCCCCCCCCCCCCCC | 74.07 | 22817900 | |
610 | Ubiquitination | AQGEPPQPPPTGQSD CCCCCCCCCCCCCCH | 42.48 | 22817900 | |
625 | Phosphorylation | YTKAWEEYYKKIGQQ HHHHHHHHHHHHCCC | 14.74 | 28152594 | |
626 | Phosphorylation | TKAWEEYYKKIGQQP HHHHHHHHHHHCCCC | 14.75 | 28152594 | |
627 | Acetylation | KAWEEYYKKIGQQPQ HHHHHHHHHHCCCCC | 36.69 | 19608861 | |
627 | Malonylation | KAWEEYYKKIGQQPQ HHHHHHHHHHCCCCC | 36.69 | 26320211 | |
627 | Ubiquitination | KAWEEYYKKIGQQPQ HHHHHHHHHHCCCCC | 36.69 | 27667366 | |
628 | Ubiquitination | AWEEYYKKIGQQPQQ HHHHHHHHHCCCCCC | 35.63 | 21906983 | |
628 (in isoform 1) | Ubiquitination | - | 35.63 | 21890473 | |
644 | Phosphorylation | GAPPQQDYTKAWEEY CCCCCCHHHHHHHHH | 13.05 | 22817900 | |
646 | Acetylation | PPQQDYTKAWEEYYK CCCCHHHHHHHHHHH | 45.32 | 26051181 | |
646 | Ubiquitination | PPQQDYTKAWEEYYK CCCCHHHHHHHHHHH | 45.32 | 21906983 | |
646 (in isoform 1) | Ubiquitination | - | 45.32 | 21890473 | |
651 | Phosphorylation | YTKAWEEYYKKQAQV HHHHHHHHHHHHHCH | 14.74 | 28152594 | |
652 | Phosphorylation | TKAWEEYYKKQAQVA HHHHHHHHHHHHCHH | 18.26 | 28152594 | |
653 | Acetylation | KAWEEYYKKQAQVAT HHHHHHHHHHHCHHC | 37.19 | 27452117 | |
653 | Malonylation | KAWEEYYKKQAQVAT HHHHHHHHHHHCHHC | 37.19 | 26320211 | |
653 | Ubiquitination | KAWEEYYKKQAQVAT HHHHHHHHHHHCHHC | 37.19 | 22817900 | |
654 | Ubiquitination | AWEEYYKKQAQVATG HHHHHHHHHHCHHCC | 34.44 | 22817900 | |
654 (in isoform 1) | Ubiquitination | - | 34.44 | 21890473 | |
670 | O-linked_Glycosylation | GPGAPPGSQPDYSAA CCCCCCCCCCCHHHH | 44.29 | 30059200 | |
670 | Phosphorylation | GPGAPPGSQPDYSAA CCCCCCCCCCCHHHH | 44.29 | 17525332 | |
674 | Phosphorylation | PPGSQPDYSAAWAEY CCCCCCCHHHHHHHH | 13.59 | 17360941 | |
681 | Phosphorylation | YSAAWAEYYRQQAAY HHHHHHHHHHHHHHH | 9.01 | - | |
682 | Phosphorylation | SAAWAEYYRQQAAYY HHHHHHHHHHHHHHH | 8.08 | - | |
688 | Phosphorylation | YYRQQAAYYGQTPGP HHHHHHHHHCCCCCC | 15.90 | 20090780 | |
689 | Phosphorylation | YRQQAAYYGQTPGPG HHHHHHHHCCCCCCC | 9.68 | 28555341 | |
692 | Phosphorylation | QAAYYGQTPGPGGPQ HHHHHCCCCCCCCCC | 26.33 | 28555341 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
193 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
193 | S | Phosphorylation | Kinase | AKT2 | P31751 | PSP |
274 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
317 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
583 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
670 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
688 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
692 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | KLHL12 | Q53G59 | PMID:27899653:32032490 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
193 | S | Phosphorylation |
| 23186163 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FUBP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EXOS2_HUMAN | EXOSC2 | physical | 15175153 | |
PARN_HUMAN | PARN | physical | 15175153 | |
PTBP2_HUMAN | PTBP2 | physical | 11003644 | |
ROA1_HUMAN | HNRNPA1 | physical | 11003644 | |
HNRH1_HUMAN | HNRNPH1 | physical | 11003644 | |
GARS_HUMAN | GARS | physical | 22863883 | |
GFPT1_HUMAN | GFPT1 | physical | 22863883 | |
HNRPD_HUMAN | HNRNPD | physical | 22863883 | |
NP1L4_HUMAN | NAP1L4 | physical | 22863883 | |
CHCH2_HUMAN | CHCHD2 | physical | 26344197 | |
CPSF6_HUMAN | CPSF6 | physical | 26344197 | |
CPSF7_HUMAN | CPSF7 | physical | 26344197 | |
FUBP3_HUMAN | FUBP3 | physical | 26344197 | |
HTRA2_HUMAN | HTRA2 | physical | 26344197 | |
KYNU_HUMAN | KYNU | physical | 26344197 | |
NUP50_HUMAN | NUP50 | physical | 26344197 | |
PRDX2_HUMAN | PRDX2 | physical | 26344197 | |
PRDX5_HUMAN | PRDX5 | physical | 26344197 | |
SIN3A_HUMAN | SIN3A | physical | 26344197 | |
SMRC1_HUMAN | SMARCC1 | physical | 26344197 | |
SMRC2_HUMAN | SMARCC2 | physical | 26344197 | |
SYMPK_HUMAN | SYMPK | physical | 26344197 | |
KLH12_HUMAN | KLHL12 | physical | 27899653 | |
CUL3_HUMAN | CUL3 | physical | 27899653 | |
RNC_HUMAN | DROSHA | physical | 29020972 | |
DGCR8_HUMAN | DGCR8 | physical | 29020972 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-87, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Phosphorylation-mediated unfolding of a KH domain regulates KSRPlocalization via 14-3-3 binding."; Diaz-Moreno I., Hollingworth D., Frenkiel T.A., Kelly G., Martin S.,Howell S., Garcia-Mayoral M., Gherzi R., Briata P., Ramos A.; Nat. Struct. Mol. Biol. 16:238-246(2009). Cited for: STRUCTURE BY NMR OF 130-218 AND 221-305, PHOSPHORYLATION AT SER-193,AND SUBCELLULAR LOCATION. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-184, ANDMASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-181; SER-274 ANDSER-480, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; THR-100; SER-181 ANDSER-184, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-181; SER-274AND SER-480, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132; SER-274 ANDSER-670, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-480, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100, AND MASSSPECTROMETRY. |